Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
Background/Aims: This study sought to investigate the expression and prognostic value of peripheral blood microRNA-448 (miR-448) and its target gene SIRT1 after laparoscopic bariatric surgery in obese type 2 diabetic mellitus (T2DM) patients. Methods: Obese T2DM patients were selected and treated wi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-02-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/487287 |
_version_ | 1818503183568207872 |
---|---|
author | Yong Wang Dong-Shu Wang Yun-Sheng Cheng Ben-Li Jia Gang Yu Xiao-Qiang Yin Yang Wang |
author_facet | Yong Wang Dong-Shu Wang Yun-Sheng Cheng Ben-Li Jia Gang Yu Xiao-Qiang Yin Yang Wang |
author_sort | Yong Wang |
collection | DOAJ |
description | Background/Aims: This study sought to investigate the expression and prognostic value of peripheral blood microRNA-448 (miR-448) and its target gene SIRT1 after laparoscopic bariatric surgery in obese type 2 diabetic mellitus (T2DM) patients. Methods: Obese T2DM patients were selected and treated with laparoscopic bariatric surgery. Enzyme-linked immunosorbent assay (ELISA) was used to measure SIRT1 protein expression. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was employed to determine the mRNA expression of the related gene. Endothelial progenitor cells (EPCs) were grouped into blank, negative control (NC), miR-448 mimic, miR-448 inhibitor, siRNA-SIRT1 and miR-448 inhibitor + siRNA-SIRT1 groups. Transwell assays and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays were applied to determine cell invasion and cell viability. A tube formation assay and an adherence test were utilized to assess the angiogenic and adhesive capacities of the cells. Results: In peripheral blood, the expression of miR-448 was reduced, whereas the mRNA and protein expression of SIRT1 was increased after surgery compared to before surgery. miR-448 expression was lower and mRNA and protein expression of SIRT1 was higher in the effective group than in the ineffective group after surgery. SIRT1 is a target gene of miR-448. miR-448 can suppress viability and invasion, and it reflects the angiogenic and adhesive capacity of EPCs and the protein expression of relative genes in EPCs through targeting SIRT1. Conclusion: The results demonstrated that miR-448 and its target gene SIRT1 can serve as prognostic indicators for obese T2DM patients after laparoscopic bariatric surgery. |
first_indexed | 2024-12-10T21:20:34Z |
format | Article |
id | doaj.art-cea96b305023423b8223b45f05911e8c |
institution | Directory Open Access Journal |
issn | 1015-8987 1421-9778 |
language | English |
last_indexed | 2024-12-10T21:20:34Z |
publishDate | 2018-02-01 |
publisher | Cell Physiol Biochem Press GmbH & Co KG |
record_format | Article |
series | Cellular Physiology and Biochemistry |
spelling | doaj.art-cea96b305023423b8223b45f05911e8c2022-12-22T01:33:09ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-02-0145393595010.1159/000487287487287Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric SurgeryYong WangDong-Shu WangYun-Sheng ChengBen-Li JiaGang YuXiao-Qiang YinYang WangBackground/Aims: This study sought to investigate the expression and prognostic value of peripheral blood microRNA-448 (miR-448) and its target gene SIRT1 after laparoscopic bariatric surgery in obese type 2 diabetic mellitus (T2DM) patients. Methods: Obese T2DM patients were selected and treated with laparoscopic bariatric surgery. Enzyme-linked immunosorbent assay (ELISA) was used to measure SIRT1 protein expression. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was employed to determine the mRNA expression of the related gene. Endothelial progenitor cells (EPCs) were grouped into blank, negative control (NC), miR-448 mimic, miR-448 inhibitor, siRNA-SIRT1 and miR-448 inhibitor + siRNA-SIRT1 groups. Transwell assays and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays were applied to determine cell invasion and cell viability. A tube formation assay and an adherence test were utilized to assess the angiogenic and adhesive capacities of the cells. Results: In peripheral blood, the expression of miR-448 was reduced, whereas the mRNA and protein expression of SIRT1 was increased after surgery compared to before surgery. miR-448 expression was lower and mRNA and protein expression of SIRT1 was higher in the effective group than in the ineffective group after surgery. SIRT1 is a target gene of miR-448. miR-448 can suppress viability and invasion, and it reflects the angiogenic and adhesive capacity of EPCs and the protein expression of relative genes in EPCs through targeting SIRT1. Conclusion: The results demonstrated that miR-448 and its target gene SIRT1 can serve as prognostic indicators for obese T2DM patients after laparoscopic bariatric surgery.https://www.karger.com/Article/FullText/487287Microrna-448SIRT1Obese type 2 diabetes mellitusLaparoscopic bariatric surgeryEfficacyPredictive value |
spellingShingle | Yong Wang Dong-Shu Wang Yun-Sheng Cheng Ben-Li Jia Gang Yu Xiao-Qiang Yin Yang Wang Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery Cellular Physiology and Biochemistry Microrna-448 SIRT1 Obese type 2 diabetes mellitus Laparoscopic bariatric surgery Efficacy Predictive value |
title | Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery |
title_full | Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery |
title_fullStr | Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery |
title_full_unstemmed | Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery |
title_short | Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery |
title_sort | expression of microrna 448 and sirt1 and prognosis of obese type 2 diabetic mellitus patients after laparoscopic bariatric surgery |
topic | Microrna-448 SIRT1 Obese type 2 diabetes mellitus Laparoscopic bariatric surgery Efficacy Predictive value |
url | https://www.karger.com/Article/FullText/487287 |
work_keys_str_mv | AT yongwang expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery AT dongshuwang expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery AT yunshengcheng expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery AT benlijia expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery AT gangyu expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery AT xiaoqiangyin expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery AT yangwang expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery |